Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT – Research Report), Dan......

UBS analyst maintained a Buy rating on Danaher today and set a price target of $270.00. In addition to UBS, Danaher also received a Buy from Barcla......

In a report released yesterday, Subbu Nambi from Guggenheim reiterated a Buy rating on Danaher, with a price target of $275.00. The company’s share......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Danaher (DHR – Research Report), Nurix Therapeutics ......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCA – Research Report) and Danaher (......

Here’s a look at today’s most important earnings reports from major publicly traded companies. Investors will be paying close attention to the resu......

U.S. stocks finished the week mixed as gains in technology shares helped offset weakness in financial stocks and rising rate pressure. The Dow Jone......

Dhruv Consultancy Services Ltd. ( ($IN:DHRUV) ) has issued an update. Dhruv Consultancy Services Limited has submitted to BSE and NSE a compliance ......

Kepler Capital analyst Baptiste de Leudeville maintained a Hold rating on Agrana Beteiligungs on January 14 and set a price target of €12.30. The c......

Kepler Capital analyst Baptiste de Leudeville maintained a Hold rating on Agrana Beteiligungs on January 8 and set a price target of €12.30. The co......